Related Experiment Video
Updated: Sep 29, 2025

In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers
Deyang Wu1, Xiaowei Liu2, Jingtian Mu1
1State Key Laboratory of Oral Diseases, National Center of Stomatology, National Clinical Research Center for Oral Diseases, Frontier Innovation Center for Dental Medicine Plus, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Abstract:
Tumor-associated macrophages (TAMs) promote tumor proliferation, invasion, angiogenesis, stemness, therapeutic resistance, and immune tolerance in a protein-dependent manner. Therefore, the traditional target paradigms are often insufficient to exterminate tumor cells. These pro-tumoral functions are mediated by the subsets of macrophages that exhibit canonical protein markers, while simultaneously having unique transcriptional features, which makes the proteins expressed on TAMs promising targets during anti-tumor therapy. Herein, TAM-associated protein-dependent target strategies were developed with the aim of either reducing the numbers of TAMs or inhibiting the pro-tumoral functions of TAMs. Furthermore, the recent advances in TAMs associated with tumor metabolism and immunity were extensively exploited to repolarize these TAMs to become anti-tumor elements and reverse the immunosuppressive tumor microenvironment. In this review, we systematically summarize these current studies to fully illustrate the TAM-associated protein targets and their inhibitors, and we highlight the potential clinical applications of targeting the crosstalk among TAMs, tumor cells, and immune cells in anti-tumor therapy.
Insights
Tumor-associated macrophages (TAMs) drive cancer growth and resistance. Targeting TAM-specific proteins offers a novel anti-tumor therapy strategy by reducing TAMs or reprogramming them to fight cancer.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor-associated macrophages (TAMs) are key regulators of tumor progression, promoting proliferation, invasion, angiogenesis, stemness, therapeutic resistance, and immune tolerance.
- Traditional anti-cancer therapies often fall short due to the complex, protein-dependent mechanisms employed by TAMs.
- TAMs possess unique transcriptional features alongside canonical protein markers, making these proteins attractive therapeutic targets.
Purpose of the Study:
- To review and summarize current strategies targeting TAM-associated proteins for anti-tumor therapy.
- To explore novel approaches for reducing TAM numbers or inhibiting their pro-tumoral functions.
- To highlight the role of TAM metabolism and immunity in reversing the immunosuppressive tumor microenvironment.
Main Methods:
- Systematic review of current literature on TAM-associated protein targets and their inhibitors.
- Analysis of recent advances in understanding TAM metabolism and immune functions.
- Exploitation of strategies to repolarize TAMs towards an anti-tumor phenotype.
Main Results:
- Identified TAM-associated proteins as promising targets for novel anti-tumor therapies.
- Demonstrated the efficacy of strategies aimed at reducing TAMs or inhibiting their pro-tumoral functions.
- Highlighted the potential of reprogramming TAMs to reverse tumor immunosuppression.
Conclusions:
- Targeting TAM-associated proteins represents a promising avenue for developing effective anti-cancer treatments.
- Repolarizing TAMs and modulating the tumor microenvironment are crucial for successful anti-tumor immunity.
- Understanding the crosstalk between TAMs, tumor cells, and immune cells is vital for clinical applications.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

